Activity of cysteine protease inhibitors in human brain tumors

Medical Science Monitor

Volumn 7, Issue 4, 2001, Pages 675-679

  Berdowska, Izabela ^a   Siewiński, Maciej ^a   Zarzycki Reich, Andrzej ^a   Jarmułowicz, Jerzy ^a   Noga, Leszek ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Astrocytoma; Brain tumors; Cystatins; Cysteine protease inhibitors; Meningioma

Indexed keywords

CATHEPSIN B; CATHEPSIN L; CYSTEINE PROTEINASE;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER SURVIVAL; CARCINOGENESIS; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MENINGIOMA; POLAND;

ASTROCYTOMA; BRAIN NEOPLASMS; CYSTEINE PROTEINASE INHIBITORS; HUMANS; MENINGIOMA;

EID: 0034928724     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cathepsin B and human tumor progression
2. Overexpression and localization of cathepsin B during the progression of human gliomas
3. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas
4. Expression and the role of cathepsin H in human glioma progression and invasion
5. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors
6. Cathepsin B and its inhibitor stefin A in brain tumors
7. Cystatins in health and disease
8. Mammalian cysteine protease inhibitors: Biochemical properties and possible roles in tumor progression
9. Cystatins
10. Cystatin C and transthyretin expression in normal and neoplastic tissues of the human brain and pituitary
11. The cerebral expression of plasma protein genes in different species
12. An improved color reagent for use in Barrett's assay of cathepsin B
13. Assay of a-cysteine proteinase inhibitor in serum or plasma
14. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
15. Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged
16. The role of b-amyloid in the development of Alzheimer's disease
17. Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases
18. Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases
19. Molecular diagnosis of hereditary cystatin C amyloid angiopathy
20. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1)
21. Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma
22. Cathepsin B and glioma invasion
23. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene